Skip to main content

Table 5 Baseline characteristics of patients utilizing Zaitaku and hospital care for short (≦10 days), medium (11-29days), long (≧30 days)-term periods

From: Cost of physician-led home visit care (Zaitaku care) compared with hospital care at the end of life in Japan

 

Zaitaku care

Hospital care

Characteristics

Short-term

(n = 9)

Medium-term

(n = 7)

Long-term

(n = 17)

p-value

Short-term

(n = 13)

Medium-term

(n = 16)

Long-term

(n = 43)

p-value

Age (mean)

71.0 ± 15.5

82.3 ± 6.1

85.5 ± 10.3

0.024**

74.9 ± 10.7

83.8 ± 9.0

80.5 ± 8.8

0.008**

Gender

   

0.011*

   

0.529*

 Female (%, n)

66.7% (n = 6)

14.3% (n = 1)

35.3% (n = 6)

 

46.2% (n = 6)

50.0% (n = 8)

34.9% (n = 15)

 

 Male (%, n)

33.3% (n = 3)

85.7% (n = 6)

64.7% (n = 11)

 

53.8% (n = 7)

50.0% (n = 8)

65.1% (n = 28)

 

Diagnosis (%, n)

 Cancer

66.7% (n = 6)

71.4% (n = 5)

64.7% (n = 11)

1.000*

76.9% (n = 10)

37.5% (n = 6)

39.5% (n = 17)

0.057*

 Dementia

33.3% (n = 3)

28.6% (n = 2)

47.1% (n = 8)

0.715*

15.4% (n = 2)

56.2%(n = 9)

41.9% (n = 18)

0.075*

Oxygen (%, n)

33.3% (n = 3)

42.9% (n = 3)

35.3% (n = 6)

1.000*

61.5% (n = 8)

87.5% (n = 14)

69.8% (n = 30)

0.271*

Infusion fluid (%, n)

88.9% (n = 8)

71.4% (n = 5)

88.2% (n = 15)

0.675*

84.6% (n = 11)

87.5% (n = 14)

100.0% (n = 43)

0.023*

Opioids (%, n)

66.7% (n = 6)

28.6% (n = 2)

35.3% (n = 6)

0.303*

76.9% (n = 10)

37.5% (n = 6)

30.2% (n = 13)

0.011*

Antibiotics (%, n)

22.2% (n = 2)

42.9% (n = 3)

23.5% (n = 4)

0.595*

7.7% (n = 1)

43.8% (n = 7)

48.8% (n = 21)

0.022*

  1. *p-values were calculated using analysis of the Fisher’s exact test
  2. **p-value was calculated using analysis of the non-parametric Kruskal-Wallis test